Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011;7(4):219–31.

Article  PubMed  Google Scholar 

Collee J, Mawet M, Tebache L, Nisolle M, Brichant G. Polycystic ovarian syndrome and infertility: overview and insights of the putative treatments. Gynecol Endocrinol. 2021;37(10):869–74.

Article  PubMed  Google Scholar 

Leal CRV, Zanolla K, Spritzer PM, Reis FM. Assisted reproductive technology in the presence of polycystic ovary syndrome: current evidence and knowledge gaps. Endocr Pract. 2024;30(1):64–9.

Article  PubMed  Google Scholar 

Howie R, Kay V. Controlled ovarian stimulation for in-vitro fertilization. Br J Hosp Med (Lond). 2018;79(4):194–9.

Article  PubMed  Google Scholar 

Esteves SC, Roque M, Bedoschi GM, Conforti A, Humaidan P, Alviggi C. Defining low prognosis patients undergoing assisted reproductive technology: POSEIDON criteria-the why. Front Endocrinol (Lausanne). 2018;9:461.

Article  PubMed  Google Scholar 

Sunkara SK, Rittenberg V, Raine-Fenning N, Bhattacharya S, Zamora J, Coomarasamy A. Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles. Hum Reprod. 2011;26(7):1768–74.

Article  PubMed  Google Scholar 

Polyzos NP, Sunkara SK. Sub-optimal responders following controlled ovarian stimulation: an overlooked group? Hum Reprod. 2015;30(9):2005–8.

Article  PubMed  Google Scholar 

Mathur RS, Tan BK. British Fertility Society Policy and Practice Committee: prevention of ovarian hyperstimulation syndrome. Hum Fertil (Camb). 2014;17(4):257–68.

Article  PubMed  Google Scholar 

Loh S, Wang JX, Matthews CD. The influence of body mass index, basal FSH and age on the response to gonadotrophin stimulation in non-polycystic ovarian syndrome patients. Hum Reprod. 2002;17(5):1207–11.

Article  PubMed  Google Scholar 

Ozekinci M, Seven A, Olgan S, Sakinci M, Keskin U, Akar ME, Ceyhan ST, Ergun A. Does obesity have detrimental effects on IVF treatment outcomes? BMC Womens Health. 2015;15:61.

Article  PubMed  PubMed Central  Google Scholar 

Rotterdam EA-SPCWG. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004, 81(1):19–25.

Ezeh U, Pisarska MD, Azziz R. Association of severity of menstrual dysfunction with hyperinsulinemia and dysglycemia in polycystic ovary syndrome. Hum Reprod. 2022;37(3):553–64.

Article  PubMed  PubMed Central  Google Scholar 

Zhu X, Ye H, Fu Y. Use of Utrogestan during controlled ovarian hyperstimulation in normally ovulating women undergoing in vitro fertilization or intracytoplasmic sperm injection treatments in combination with a "freeze all" strategy: a randomized controlled dose-finding study of 100 mg versus 200 mg. Fertil Steril. 2017;107(2):379–386 e374.

Biasoni V, Patriarca A, Dalmasso P, Bertagna A, Manieri C, Benedetto C, Revelli A. Ovarian sensitivity index is strongly related to circulating AMH and may be used to predict ovarian response to exogenous gonadotropins in IVF. Reprod Biol Endocrinol. 2011;9:112.

Article  PubMed  PubMed Central  Google Scholar 

Guo Y, Liu W, Wang Y, Pan J, Liang S, Ruan J, Teng X. Polarization microscopy imaging for the identification of unfertilized oocytes after short-term insemination. Fertil Steril. 2017;108(1):78–83.

Article  PubMed  Google Scholar 

Wallace WH, Kelsey TW. Human ovarian reserve from conception to the menopause. PLoS ONE. 2010;5(1):e8772.

Article  PubMed  PubMed Central  Google Scholar 

Sampo AV, Palena C, Ganzer L, Maccari V, Estofan G, Hernandez M. The adverse effect of overweight in assisted reproduction treatment outcomes. JBRA Assist Reprod. 2017;21(3):212–6.

PubMed  PubMed Central  Google Scholar 

La Marca A, Sighinolfi G, Argento C, Grisendi V, Casarini L, Volpe A, Simoni M: Polymorphisms in gonadotropin and gonadotropin receptor genes as markers of ovarian reserve and response in in vitro fertilization. Fertil Steril 2013, 99(4):970–978 e971.

Vembu R, Reddy NS. Serum AMH level to predict the hyper response in women with PCOS and non-PCOS undergoing controlled ovarian stimulation in ART. J Hum Reprod Sci. 2017;10(2):91–4.

Article  PubMed  PubMed Central  Google Scholar 

Joo BS, Park SH, An BM, Kim KS, Moon SE, Moon HS. Serum estradiol levels during controlled ovarian hyperstimulation influence the pregnancy outcome of in vitro fertilization in a concentration-dependent manner. Fertil Steril. 2010;93(2):442–6.

Article  PubMed  Google Scholar 

Bu Z, Zhao F, Wang K, Guo Y, Su Y, Zhai J, Sun Y. Serum progesterone elevation adversely affects cumulative live birth rate in different ovarian responders during in vitro fertilization and embryo transfer: a large retrospective study. PLoS ONE. 2014;9(6):e100011.

Article  PubMed  PubMed Central  Google Scholar 

Zhou SJ, Zhao MJ, Li C, Su X. The comparison of evaluative effectiveness between antral follicle count/age ratio and ovarian response prediction index for the ovarian reserve and response functions in infertile women. Medicine (Baltimore). 2020;99(36):e21979.

Article  PubMed  Google Scholar 

Vural F, Vural B, Cakiroglu Y. The role of overweight and obesity in in vitro fertilization outcomes of poor ovarian responders. Biomed Res Int. 2015;2015:781543.

Article  PubMed  PubMed Central  Google Scholar 

Kilic S, Yilmaz N, Zulfikaroglu E, Sarikaya E, Kose K, Topcu O, Batioglu S. Obesity alters retrieved oocyte count and clinical pregnancy rates in high and poor responder women after in vitro fertilization. Arch Gynecol Obstet. 2010;282(1):89–96.

Article  PubMed  Google Scholar 

Perez Mayorga M, Gromoll J, Behre HM, Gassner C, Nieschlag E, Simoni M. Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab. 2000;85(9):3365–9.

PubMed  Google Scholar 

Alviggi C, Conforti A, Santi D, Esteves SC, Andersen CY, Humaidan P, Chiodini P, De Placido G, Simoni M. Clinical relevance of genetic variants of gonadotrophins and their receptors in controlled ovarian stimulation: a systematic review and meta-analysis. Hum Reprod Update. 2018;24(5):599–614.

Article  PubMed  Google Scholar 

Polyzos NP, Neves AR, Drakopoulos P, Spits C, Alvaro Mercadal B, Garcia S, Ma PQM, Le LH, Ho MT, Mertens J, et al. The effect of polymorphisms in FSHR and FSHB genes on ovarian response: a prospective multicenter multinational study in Europe and Asia. Hum Reprod. 2021;36(6):1711–21.

Article  PubMed  Google Scholar 

Vazquez AC, Rodriguez J, Algara ALC, Garcia JDM. Correlation between biochemical, ultrasonographic and demographic parameters with ovarian response to IVF/ICSI treatments in Mexican women. JBRA Assist Reprod. 2021;25(1):4–9.

PubMed  PubMed Central  Google Scholar 

Cortes-Vazquez A, Goitia-Landeros GA, Regalado MA, Leon-Hernandez SR, Cortes-Algara AL, Bandala C, Moreno-Garcia JD, Drakopoulos P. Prediction of ovarian response in IVF/ICSI cycles. JBRA Assist Reprod. 2021;25(3):422–7.

PubMed  PubMed Central  Google Scholar 

Huhtaniemi I, Alevizaki M. Gonadotrophin resistance. Best Pract Res Clin Endocrinol Metab. 2006;20(4):561–76.

Article  PubMed  Google Scholar 

Pigny P, Jonard S, Robert Y, Dewailly D. Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91(3):941–5.

Article  PubMed  Google Scholar 

Franks S, Stark J, Hardy K. Follicle dynamics and anovulation in polycystic ovary syndrome. Hum Reprod Update. 2008;14(4):367–78.

Article  PubMed  Google Scholar 

Akbari Sene A, Ashrafi M, Alaghmand-Fard N, Mohammadi N, MortezapourAlisaraie M, Alizadeh A. Anti-Mullerian hormone predictive levels to determine the likelihood of ovarian hyper-response in infertile women with polycystic ovarian morphology. Int J Fertil Steril. 2021;15(2):115–22.

PubMed  PubMed Central  Google Scholar